A predictive model to identify Parkinson disease from administrative claims data
- PMID: 28864676
- PMCID: PMC5631173
- DOI: 10.1212/WNL.0000000000004536
A predictive model to identify Parkinson disease from administrative claims data
Abstract
Objective: To use administrative medical claims data to identify patients with incident Parkinson disease (PD) prior to diagnosis.
Methods: Using a population-based case-control study of incident PD in 2009 among Medicare beneficiaries aged 66-90 years (89,790 cases, 118,095 controls) and the elastic net algorithm, we developed a cross-validated model for predicting PD using only demographic data and 2004-2009 Medicare claims data. We then compared this model to more basic models containing only demographic data and diagnosis codes for constipation, taste/smell disturbance, and REM sleep behavior disorder, using each model's receiver operator characteristic area under the curve (AUC).
Results: We observed all established associations between PD and age, sex, race/ethnicity, tobacco smoking, and the above medical conditions. A model with those predictors had an AUC of only 0.670 (95% confidence interval [CI] 0.668-0.673). In contrast, the AUC for a predictive model with 536 diagnosis and procedure codes was 0.857 (95% CI 0.855-0.859). At the optimal cut point, sensitivity was 73.5% and specificity was 83.2%.
Conclusions: Using only demographic data and selected diagnosis and procedure codes readily available in administrative claims data, it is possible to identify individuals with a high probability of eventually being diagnosed with PD.
© 2017 American Academy of Neurology.
Figures
Comment in
-
Reader response: A predictive model to identify Parkinson disease from administrative claims data.Neurology. 2018 Jul 10;91(2):104. doi: 10.1212/WNL.0000000000005768. Neurology. 2018. PMID: 29987182 No abstract available.
-
Author response: A predictive model to identify Parkinson disease from administrative claims data.Neurology. 2018 Jul 10;91(2):104. doi: 10.1212/WNL.0000000000005767. Neurology. 2018. PMID: 29987183 No abstract available.
References
-
- Parkinson Study Group. Effect of deprenyl on the progression of disability in early Parkinson's disease. N Engl J Med 1989;321:1364–1371. - PubMed
-
- Parkinson Study Group PRECEPT Investigators. Mixed lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson disease. Neurology 2007;69:1480–1490. - PubMed
-
- Olanow CW, Rascol O, Hauser R, et al. . A double-blind, delayed-start trial of rasagiline in Parkinson's disease. N Engl J Med 2009;361:1268–1278. - PubMed
-
- Olanow CW, Goetz CG, Kordower JH, et al. . A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol 2003;54:403–414. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical